Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study | Journal of Translational Medicine | Full Text

Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study | Journal of Translational Medicine | Full Text

Journal of Translational Medicine

Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study

Non-alcoholic fatty liver disease (NAFLD) is characterized by triglyceride accumulation in the hepatocytes in the absence of alcohol overconsumption, commonly associated with insulin resistance and obesity. Bo...

Authors:Benedetta M. Motta, Christoph Grander, Martin Gögele, Luisa Foco, Vladimir Vukovic, Roberto Melotti, Christian Fuchsberger, Alessandro De Grandi, Chiara Cantaloni, Anne Picard, Deborah Mascalzoni, Alessandra Rossini, Cristian Pattaro, Herbert Tilg and Peter P. Pramstaller

Citation:Journal of Translational Medicine 2019 17:408

Content type:Protocol

Published on: 4 December 2019

• ViewFull Text
 
• ViewPDF